title: Antibiotics and pregnancy.
abstract: Like anybody else, pregnant women are susceptible to infections. The correct treatment of these women, however, must consider along with pathogens, the infection site and antibiotic pharmacokinetics, the fetus and possible side effects to the child. When prescribing over this special condition, the physician must remember that the prescription will affect two organism and the drug must treat the mother without affecting the fetus. Beta-lactams having a long history of use without significant deleterious effects on the fetuses still are the safest choice during pregnancy. However, considering the constant increase of multi-resistant microorganisms, the physician has been forced to use different antimicrobial agents. Usually, data regarding safety during pregnancy are very limited, which causes serious doubts during prescription. In addition, many studies regarding the safe use of antibiotics during pregnancy are inconclusive or demand more evidence. The present study is a wide revision regarding the use of antibiotics during pregnancy, considering their pharmacokinetics and the clinical experience in recent years. It also intends to assist the physician during prescription and to give information to the pharmacists to help pregnant women.
authors.affiliation: Pharmacology Department, School of Pharmacy of University of Sorocaba, Campinas State University, UNICAMP, Brazil.
authors.forename: F
authors.initials: F
authors.lastname: Sá del Fiol
authors.forename: M
authors.initials: M
authors.lastname: Gerenutti
authors.forename: F C
authors.initials: FC
authors.lastname: Groppo
mesh_terms: D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000145:classification / Q000493:pharmacokinetics; D001419:Bacteria / Q000187:drug effects / Q000378:metabolism; D005260:Female; D006801:Humans; D008431:Maternal-Fetal Exchange; D019384:Nucleic Acid Synthesis Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics; D011247:Pregnancy / Q000502:physiology*; D011500:Protein Synthesis Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics
chemical_list: D000900:Anti-Bacterial Agents; D019384:Nucleic Acid Synthesis Inhibitors; D011500:Protein Synthesis Inhibitors